nach oben

Journal of General Internal Medicine

Erschienen in:

01.06.2012 | Original Research

The Placebo Phenomenon: Implications for the Ethics of Shared Decision-Making

verfasst von: Howard Brody, MD, PhD, Luana Colloca, MD, PhD, Franklin G. Miller, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Recent research into the placebo effect has implications for the ethics of shared decision-making (SDM). The older biomedical model views SDM as affecting which therapy is chosen, but not the nature or likelihood of any health outcomes produced by the therapy. Research indicates, however, that both the content and manner in which information is shared with the patient, and the patient’s experience of being involved in the decision, can directly alter therapeutic outcomes via placebo responses. An ethical tension is thereby created between SDM aimed strictly and solely at conveying accurate information, and “outcome engineering” in which SDM is adapted toward therapeutic goals. Several practical strategies mitigate this tension and promote respect for autonomous decision-making while still utilizing the therapeutic potential of SDM.

Peabody FW. The care of the patient. J Am Med Assn. 1927;88:877–82.CrossRef

Harrington A. The cure within: a history of mind-body medicine. New York: Norton; 2008.

Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–36.PubMedCrossRef

Benedetti F. Placebo effects: understanding the mechanisms in health and disease. New York: Oxford University Press; 2009.

Hahn RA. The nocebo phenomenon: scope and foundations. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge, MA: Harvard University Press; 1997:56–76.

Guess HA, Kleinman A, Kusek JW, Engel LW. The science of the placebo: toward an interdisciplinary research agenda. London: BMJ Books; 2002.

Colloca L, Miller FG. Role of expectations in health. Curr Opin Psychiatry. 2011;24:149–155.PubMedCrossRef

Tilburt JC, Emanuel EJ, Kaptchuk TJ, et al. Prescribing ‘placebo treatments’: results of national survey of US internists and rheumatologists. BMJ. 2008; 337:a1938.

Kermen R, Hickner J, Brody H, Hasham I. Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos. Fam Med. 2010;42:636–42.PubMed

10.

Patient Protection and Affordable Care Act, Title III, Subtitle F. Sec. 3506. Program to facilitate shared decisionmaking. http://en.wikisource.org/wiki/Patient_Protection_and_Affordable_Care_Act/Title_III/Subtitle_F#SEC._936._PROGRAM_TO_FACILITATE_SHARED_DECISIONMAKING. (accessed December 19, 2011).

11.

Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60:301–312.PubMedCrossRef

12.

Moumjid N, Gafni A, Brémond A, Carrère MO. Shared decision making in the medical encounter: are we all talking about the same thing? Med Decis Making. 2007;27:539–546.PubMedCrossRef

13.

Weinstein JN, Clay K, Morgan TS. Informed patient choice: patient-centered valuing of surgical risks and benefits. Health Aff (Millwood). 2007;26:726–730.CrossRef

14.

Moulton B, King JS. Aligning ethics with medical decision-making: the quest for informed patient choice. J Law Med Ethics. 2010;38:85–97.PubMedCrossRef

15.

O’Connor AM, Wennberg JE, Legare F, et al. Toward the tipping point: decision aids and informed patient choice. Health Aff (Millwood). 2007;26:716–725.CrossRef

16.

Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Making health care decisions. Part 1: Report. Washington, DC: US Government Printing Office, 1982:31.

17.

Faden RR, Beauchamp TL. A history and theory of informed consent. New York: Oxford University Press; 1986.

18.

Katz J. The silent world of doctor and patient. New York: Free Press; 1984.

19.

Kalauokalani D, Cherkin DC, Sherman KJ, et al. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine. 2001;26:1418–24.PubMedCrossRef

20.

Brody H, Miller FG. Lessons from recent research about the placebo effect—from art to science. JAMA. 2011;306:2612–3.PubMedCrossRef

21.

Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care: effects on patient outcomes. Ann Intern Med. 1985;102:520–8.PubMed

22.

Leopold N, Cooper J, Clancy C. Sustained partnership in primary care. J Fam Pract. 1996;42:129–37.PubMed

23.

Di Blasi Z, Harkness E, Ernst E, et al. Influence of context effects on health: a systematic review. Lancet. 2001;357:757–62.PubMedCrossRef

24.

Crow R, Gage H, Hampson S, et al. The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol Assess. 1999;3(3):1–96.PubMed

25.

Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152:1423–33.PubMed

26.

Street RL, Makoul G, Arora NK, Epstein RM. How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Educ Couns. 2009;74:295–301.PubMedCrossRef

27.

Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety and Parkinson’s disease. Lancet Neurol. 2004;3:679–84.PubMedCrossRef

28.

Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of the placebo effect: randomized controlled trial in patients with irritable bowel syndrome. BMJ. 2008;336:999–1003.PubMedCrossRef

29.

Miller FG, Colloca L. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth. 2011; doi:10.1007/s11017-011-9179-8

30.

Green JA. Minimizing malpractice risks by role clarification. The confusing transition from tort to contract. Ann Intern Med. 1988;109:234–41.PubMed

31.

Emanuel EJ. Emanuel LL Four models of the physician-patient relationship. JAMA. 1992;267:2221–26.PubMedCrossRef

32.

Brody H. Transparency: informed consent in primary care. Hastings Cent Rep. 1989;19(5):5–9.PubMedCrossRef

33.

Kurz-Milcke E, Gigerenzer G, Martignon L. Transparency in risk communication: graphical and analog tools. Ann NY Acad Sci. 2008;1128:18–28.PubMedCrossRef

34.

Kaptchuk TJ, Friedlander E, Kelley JM. Placebo effect without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE. 2010;5(12):e15591.PubMedCrossRef

35.

Colloca L, Miller FG. The nocebo effect and its relevance for clinical practice. Psychosom Med. 2011;73:598–603.PubMedCrossRef

36.

O’Connor AM, Pennie RA, Dales RE. Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization. J Clin Epidemiol. 1996;49:1271–76.PubMedCrossRef

37.

Ferguson E, Gallagher L. Message framing with respect to decisions about vaccination: the roles of frame valence, frame method and perceived risk. Br J Psychol. 2007;98:667–80.PubMedCrossRef

Titel: The Placebo Phenomenon: Implications for the Ethics of Shared Decision-Making
verfasst von: Howard Brody, MD, PhD
Luana Colloca, MD, PhD
Franklin G. Miller, PhD
Publikationsdatum: 01.06.2012
Verlag: Springer-Verlag
Erschienen in: Journal of General Internal Medicine / Ausgabe 6/2012
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-011-1977-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2012

Newer Is Not Always Better: All Antihypertensive Medications Do Not Equally Reduce Cardiovascular Risk

Attitudes and Preferences Toward the Provision of Medication Abortion in an Urban Academic Internal Medicine Practice

A 60-Year-Old Woman with Chorea and Weight Loss

Blood Pressure Monitoring Technique Impacts Hypertension Treatment

Nurse-led Disease Management for Hypertension Control in a Diverse Urban Community: a Randomized Trial